SAB Biotherapeutics, Inc.
SEC CIK 1833214 · SABS · last insider filing 2026-06-26
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Reich Samuel J | Director · Executive Chairman | filed 2021 - 2026 |
| Sullivan Eddie Joe | Director · PRESIDENT | filed 2021 - 2026 |
| Zaccardelli David | Director | filed 2026 - 2026 |
| Jain Rita | Director | filed 2026 - 2026 |
| Skyler JAY S | Director | filed 2024 - 2025 |
| Lucera Erick | Director | filed 2023 - 2025 |
| Polvino William James | Director | filed 2021 - 2025 |
| Giberson Scott | Director | filed 2022 - 2025 |
| Ellias Helen K. | Director | filed 2023 - 2025 |
| Link David | Director | filed 2025 - 2025 |
| Sessa Capital IM, L.P. | Director | filed 2023 - 2025 |
| Sessa Capital (Master), L.P. | Director | filed 2023 - 2025 |
| Sessa Capital GP, LLC | Director | filed 2023 - 2025 |
| Sessa Capital IM GP, LLC | Director | filed 2023 - 2025 |
| Petry John | Director | filed 2023 - 2025 |
| Moin Andrew | Director | filed 2023 - 2025 |
| Hamilton Christine E | Director | filed 2021 - 2024 |
| Spragens Jeffrey G | Director | filed 2021 - 2024 |
| Link David Charles | Director | filed 2021 - 2024 |
| Turner Mervyn | Director | filed 2021 - 2021 |
| Katz Ilan | Director | filed 2021 - 2021 |
| Big Cypress Holdings LLC | Director · CEO and CFO | filed 2021 - 2021 |
| Martin James Joseph | Director | filed 2021 - 2021 |
| Collins Stephen D. | Director | filed 2021 - 2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Kropotova Alexandra | Chief Medical Officer | filed 2022 - 2026 |
| Bausch Christoph Lawrence | Chief Science Officer | filed 2021 - 2026 |
| To Lucy | See Remarks | filed 2024 - 2026 |
| Conley Mark William | See Remarks | filed 2024 - 2024 |
| King Michael | CHIEF FINANCIAL OFFICER | filed 2023 - 2024 |
| Beyer Russell P | Chief Financial Officer | filed 2021 - 2023 |
| Finnegan Frederick | Chief Business Officer | filed 2021 - 2022 |
| Pommer Jerry Lynn | Chief Compliance Officer | filed 2021 - 2022 |
| Erickson Bruce Kipp | Chief Operating Officer | filed 2021 - 2022 |
| Luke Thomas Charles | Chief Medical Officer | filed 2021 - 2022 |
| Ullerich Melissa Vera | Chief Communications Officer | filed 2021 - 2022 |
| Wu Hua | SVP Research & Product Dev. | filed 2021 - 2021 |
| Carillo Carlos N | SVP Regulatory Affairs | filed 2021 - 2021 |
| Randall Charles Hiram | Chief Strategy Officer | filed 2021 - 2021 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.